Archives of Disease in Childhood · 1987 · 26 citations · 4 references
PharmacyPediatricsPharmacotherapyHemostasisNeonatologyPediatric Clinical PharmacologyCoagulation Factor DeficienciesNeonatal PharmacologyVitamin K TherapyVitamin PhysiologyNeonatal Vitamin K ProphylaxisOral Vitamin K AdministrationOral Vitamin K Supplementation
The effect of prophylaxis with oral vitamin K (1 mg vitamin K1 given with the first feed) on the rate of detection of acarboxyprothrombin (PIVKA II) and factor II clotting concentration [corrected] were analysed. Introducing such prophylaxis reduced the rates of detection of PIVKA II concentration [corrected] on day 5 from 48% to zero. None of the babies given prophylaxis had factor II clotting concentration [corrected] below 40%, compared with 34 of 95 babies not given prophylaxis. This study has important implications in the prophylaxis of both classical and late onset haemorrhagic disease of the newborn.
4
Plasma concentrations after oral or intramuscular vitamin K1 in neonates.
A W McNinch, Clare Upton, Mary H. Samuels et al. · Archives of Disease in Childhood · 1985 · 119 citations · Full text
Hemorrhage in the newborn and vitamin K prophylaxis
Karl W. Wefring · The Journal of Pediatrics · 1962 · 33 citations
Medicine, Child Health, Pediatrics +11